Immunoglobulin immobilized liposomal constructs for transmucosal vaccination through nasal route

References

• Abraham, E. (1992). Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 107:461–468.
   Google Scholar
• Alcon, V. L., Baca-Estrada, M., Vega-López, M. A., Willson, P, Babiuk,  L. A., Kumar, P., et al. (2005). Intranasal immunization using biphasic lipid vesicles as delivery systems for OmlA bacterial protein antigen and CpG oligonucleotides adjuvant in a mouse model. J Pharm Pharmacol 57:955–962.
   PubMed Web of Science ®Google Scholar
• Adler, A. J., Greenfield, N. J., Fasman, G. D. (1973). Circular dichroism and optical rotator dispersion of proteins and polypeptides. Meth Enzymol 27:675– 735.
   PubMedGoogle Scholar
• Bersted, A. K. H., Anderson, S. R., Delseg, R., Dromtorp, S., Holst,  J., Namork, E. (2000). Inactivated meningococci and pertissis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus. Vaccine 18:1910–1919.
   PubMedGoogle Scholar
• Chen, H., Jiang, J. H., Li, Y. F., Deng, T., Shen, G. L., Yu, R. Q. (2007). A novel piezoelectric immunoagglutination assay technique with antibody-modified liposome. Biosens Bioelectron 22:993–999.
   PubMedGoogle Scholar
• Chiou, C. J., Tseng, L. P., Deng, M. C., Jiang, P. R., Tasi, S. L., Chung, T. W., et al. (2009). Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens. Biomaterials 30:5862–5868.
   PubMed Web of Science ®Google Scholar
• Clark, M. A., Hirst, B. H., Jepson, M. A. (2000). Lectin-mediated mucosal delivery of drugs and microparticles. Adv Drug Deliv Rev 432:207–223.
   Google Scholar
• Dapergolas, G., Gregoriadis, G. (1976). Oral administration of insulin by encapsulation within liposomes. Lancet 2:824–827.
   PubMed Web of Science ®Google Scholar
• Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L., Sperandio, S., Melber, K. (2002). Intranasal immunization with recombinant antigens associated with new cationic particle induces strong mucosal as well as systemic antibody and CTL responses. Vaccine 20:2752–2763.
   PubMed Web of Science ®Google Scholar
• Drury, R. A. B., Wallington, E. A., Cameron, R. (1976). Carleton’s histological technique, 4th ed (pp 114–137). Oxford, UK: Oxford University Press.
   Google Scholar
• Elbayoumi, T. A., Torchilin, V. P. (2006). Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody, 2C5, in various tumours in mice: gamma-imaging studies. Eur J Nucl Med Mol Imaging 33:1196–1205.
   PubMed Web of Science ®Google Scholar
• Elbayoumi, T. A., Torchilin, V. P. (2007). Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. Eur J Pharm Sci 3:159–168.
   Google Scholar
• Ermak, T. H., Giannasca, P. J. (1998). Microparticle targeting to M cells. Adv Drug Deliv Rev 342:261–283.
   Google Scholar
• Frézard, F. (1999). Liposomes: from biophysics to the design of peptide vaccines. Braz J Med Biol Res 322:181–189.
   Google Scholar
• Fry, D. W., White, J. C., Goldman, I. D. (1978). Rapid separation of low molecular weight solute from liposomes without dilution. Anal Biochem 90:809–815.
   PubMed Web of Science ®Google Scholar
• Gupta, P. N., Mahor, S., Rawat, A., Khatri, K., Goyal, A., Vyas, S. P. (2006). Non-invasive vaccine delivery in transferrosomes, niosomes and liposomes: a comparative study. Int J Pharm 318:163–173.
   PubMed Web of Science ®Google Scholar
• Gupta, R. K., Rost, B. E. (1999). Aluminum compounds as vaccine adjuvants. Meth Mol Med 42:65–89.
   Google Scholar
• Haan, A. D., Geerligs, H. J., Huchshorn, J. P., Scharrenburg, G. J. M. V., Palache, A. M., Wilschut, J. (1995). Mucosal immunoadjuvent activity of liposomes: induction of systemic IgG and secretary IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine 132:155–162.
   Google Scholar
• Harokopakis, E., Childers, N. K., Michalek, S. M., Zhang, S. S., Tomasi,  M. (1995). Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens. J Immunol Meth 1851:31–42.
   Google Scholar
• Harokopakis, E., Hajishengallis, G., Michalek, S. M. (1998). Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect Immun 669:4299–4304.
   Google Scholar
• Hemker, H. C., Hermans, W. T., Muller, A. D., Zawal, R. F. A. (1980). Oral treatment of hemophilia by a gastrointestinal absorption of factor VIII entrapped in liposomes. Lancet 1:70–71.
   PubMed Web of Science ®Google Scholar
• Jaganathan, K. S., Vyas, S. P. (2006). Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 24:4201–4211.
   PubMed Web of Science ®Google Scholar
• Jain, S., Sharma, R. K., Vyas, S. P. (2006a). Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in vitro, and in vivo characterization. J Pharm Pharmacol 58:303–310.
   PubMed Web of Science ®Google Scholar
• Jain, S., Vyas, S. P. (2006b). Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res 16:331–345.
   PubMed Web of Science ®Google Scholar
• Kool, M., Soullie, T., Nimwegen, M. V., Willart, M. A. M., Muskens, F., Jung, S., et al. (2008). Alum adjuvant boost adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2054:869–882.
   Google Scholar
• McGhee, J. R., Lamm, M. E., Strober, W. (1999). Mucosal immune responses. In: Ogra, P. L., Mestecky, J., Lamm, M. E., Strober, W., Bienenstock, J., et al. (Eds.), Mucosal immunology, vol. 2 (pp 485–506). San Diego, California, USA: Academic Press.
   Google Scholar
• Nakane, A., Numata, A., Minagawa, T. (1992). Tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect Immun 60:523–528.
   PubMed Web of Science ®Google Scholar
• Nakano, Y., Mori, M., Nishinohra, S., Takita, Y., Naito, S., Kato, H., et al. (2001). Surface-linked liposomal antigen induces IgE-selective unresponsiveness regardless of the lipid components of liposomes. Bioconj Chem 12:48–53.
   Google Scholar
• Neutra, M. R, Kraehenbuhl, J. P. (1992). Transepithelial transport and mucosal defense. I: the role of M cells. Trends Cell Biol 2:134–138.
   PubMedGoogle Scholar
• Patel, H. M., Rayman, B. E. (1976). Oral administration of insulin by encapsulation within liposomes. FEBS Lett 62:60–63.
   PubMed Web of Science ®Google Scholar
• Porta, C., James, P. S., Phillips, A. D., Savidge, T. C., Smith, M. W., Cremaschi, D. (1992). Confocal analysis of fluorescent bead uptake by mouse Peyer’s patches. Exp Physiol 77:929–932.
   PubMed Web of Science ®Google Scholar
• Rai, S., Paliwal, R., Vaidya, B., Khatri, K., Goyal, A. K., Gupta, P. N., et al. (2008). Targeted delivery of doxorubicin via estrone-appended liposomes. J Drug Targ 16:455–463.
   PubMed Web of Science ®Google Scholar
• Ramyen, B. E., Jewkes, R. F., Jeyasingh, K., Osborne, M. P., Patel, H. M., Richardson, V. J., et al. (1978). Potential applications of liposomes to therapy. Ann N Y Acad Sci 308:281–307.
   PubMedGoogle Scholar
• Saraf, S., Mishra, D., Asthana, A., Jain, R., Singh, S, Jain, N. K. (2006). Lipid microparticles for mucosal immunization against hepatitis B. Vaccine 24:45–56.
   PubMed Web of Science ®Google Scholar
• Shukla, A., Katare, O. P., Singh, B., Vyas, S. P. (2010). M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm 385:47–52.
   PubMed Web of Science ®Google Scholar
• Singh, P., Prabakaran, D., Jain, S., Mishra, V., Jaganathan, K. S., Vyas, S. P. (2004). Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm 278:379–390.
   PubMed Web of Science ®Google Scholar
• Sjolander, S., Drane, D., Davis, R., Beezum, L., Pearse, M., Cox, J. (2001). Intranasal immunization with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. Vaccine 19:4072–4080.
   PubMed Web of Science ®Google Scholar
• Smirnov, V. N., Domogatsky, S. P., Dolgov, V. V., Hvatov, V. B., Klibanov,  A. L., Koteliansky, V. E., et al. (1986). Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A 83:6603–6607.
   PubMed Web of Science ®Google Scholar
• Smith, M. W., Thomas, N. W., Jenkins, P. G., Miller, N. G. A., Cremaschi,  D., Porta, C. (1995). Selective transport of microparticles across Peyer’s patch follicle-associated M cells from mice and rats. Exp Physiol 80:735–743.
   PubMed Web of Science ®Google Scholar
• Spreng, S., Dietrich, G., Weidinger, G. (2006). Rational design of Salmonella-based vaccination strategies. Methods 38:133–143.
   PubMed Web of Science ®Google Scholar
• Tiwari, S., Goyal, A. K., Mishra, N., Khatri, K., Vaidya, B., Mehta, A., et al. (2009) Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. J Contr Rel 140:157–165.
   PubMed Web of Science ®Google Scholar
• Tizard, I. R. (2004). Immunology: an introduction, 4th ed (p 73). Singapore: Thomson Pte. Ltd.
   Google Scholar
• Torchilin, V. P., Khaw, B. A., Smirnov, V. N., Haber, E. (1979). Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophy Res Commun 894:1114–1119.
   Google Scholar
• Utreja, S., Jain, N. K. (2001). Solid lipid nanoparticles. In: Jain, N. K. (Ed.), Advances in controlled and novel drug delivery, 1st ed. (pp 408–424). New Delhi, India: CBS Publishers and Distributors.
   Google Scholar
• Vajdy, M., O’Hangan, D. T. (2001). Microparticles for intranasal immunization. Adv Drug Del Rev 51:127–141.
   PubMed Web of Science ®Google Scholar
• Velez, C. N., Tonkonogy, S. L., Lichtman, S. N., Cho, M. J. (1997). Sensitized liposomes as an antigen delivery system for the stimulation of mucosal immunity. J Drug Targ 5:15–24.
   PubMed Web of Science ®Google Scholar
• Wang, D., Christopher, M. E., Nagata, L. P., Zabielski, M. A., Li, H., Wong,  J. P. (2004). Intranasal immunization with liposome encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular, and humoral immune responses. Clin Virol 31:99–106.
   PubMed Web of Science ®Google Scholar
• Yuki, Y., Kiyono, H. (2003). New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 13:293–310.
   PubMed Web of Science ®Google Scholar
• Zhou, F., Kraehenbuhl, J. P., Neutra, M. R. (1995). Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine 137:637–644.
   Google Scholar